Cognetivity's AI solutions to transform cognitive testing
Posted:
Cognetivity's VP, Mazen Sobh, explores the use of Artificial Intelligence technology in healthcare & its potential for medicine in cognitive neuroscience. Read more here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.